Global Med Technologies(R), Inc. Announces First Vein-to-Vein(R) Site in Florida
April 22 2005 - 11:00AM
PR Newswire (US)
Global Med Technologies(R), Inc. Announces First Vein-to-Vein(R)
Site in Florida Suncoast Communities Blood Bank Selects SafeTrace
Tx(R) Advanced Transfusion Management System DENVER, April 22
/PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of
Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB)
("Global Med" or the "Company"), has signed an agreement with
Suncoast Communities Blood Bank ("SCBB") to provide its SafeTrace
Tx(R) advanced transfusion management system. Terms were not
disclosed. SCBB also recently purchased SafeTrace(R), Wyndgate's
donor management solution. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Mark
Magenheim, MD, MPH, CEO and Medical Director of Suncoast
Communities Blood Bank, said, "Wyndgate has successfully developed
software to manage the complexities of our transfusion service
business. We were presented with the options and advantages of
SafeTrace Tx after receiving notification that our current solution
was being 'sunsetted.' We selected SafeTrace Tx for its
comprehensive safety features, application capabilities, and
central transfusion service, which will facilitate our vision of
SCBB's future." Dr. Magenheim continued, "Other factors influencing
SCBB's decision to purchase SafeTrace Tx were Wyndgate's market
experience, reputation, application functionality, product
lifecycle, implementation experience, product support and
commitment to our future." "We are very pleased to announce this
major agreement with Suncoast Communities Blood Bank, a prestigious
community blood center on the Sun Coast of Florida. Our
relationship with Suncoast highlights Wyndgate's commitment to
quality, safety and service, by partnering with Suncoast to
optimize its transfusion operations," said Thomas F. Marcinek,
President and COO of Global Med Technologies, Inc. About Suncoast
Communities Blood Bank In 1949, O. K. Fike and Dr. Millard White
founded the region's first blood bank, located within Sarasota
Memorial Hospital. In 1999, the celebration of 50 years of service
to the lower west coast of Florida was heralded by 50 events in 50
weeks and the adoption of a new motto, "Generous Hearts Saving
Precious Lives." With the acquisition of the former Gulf Area
Regional Blood Bank in Venice, the blood bank now provides
opportunities for blood donations to citizens in Sarasota, DeSoto,
and Charlotte counties. For more information about Suncoast
Communities Blood Bank, visit its website at http://www.scbb.org/.
About Global Med Technologies, Inc. Global Med Technologies, Inc.
is an international e-Health, medical information technology
company, providing information management software products and
services to the healthcare industry. Its Wyndgate Technologies
division is a leading supplier of information management systems to
U.S. and international blood centers and hospital transfusion
centers. Current clients of Wyndgate's products and services manage
more than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Wyndgate's products are also being implemented
in Canada, the Caribbean and sub-Sahara Africa. Together, the
SafeTrace Tx* advanced transfusion management system and the
SafeTrace donor management system provide Vein-to-Vein(R) tracking
from donor collection to patient transfusion. For more information
about Global Med's products and services, please call 800-WYNDGATE
or visit http://www.globalmedtech.com/, http://www.peoplemed.com/
and http://www.wyndgate.com/. This news release may include
statements that constitute forward-looking statements, usually
containing the words "believe," "estimate," "project," "expects" or
similar expressions. These statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies(R),
Inc., +1-303-238-2000, or Investors, John Nesbett or Jordan
Silverstein, both of The Investor Relations Group, +1-212-825-3210,
for Global Med Technologies, Inc. Web site:
http://www.peoplemed.com/ Web site: http://www.scbb.org/ Web site:
http://www.wyndgate.com/ Web site: http://www.globalmedtech.com/
Copyright